Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-13 Purchase | 2022-05-17 5:35 pm | Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director | 3,828 | $4.829 | $18,486 | 7,328 (Direct) | View |
| 2022-04-12 Purchase | 2022-04-14 4:53 pm | Lyra Therapeutics Inc. | LYRA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive LS (A) LLC EDELMAN JOSEPH Director 10% Owner | 5,924,170 | $4.22 | $24,999,997 | 9,146,731 (Indirect) | View |
| 2022-04-12 Purchase | 2022-04-14 4:14 pm | Lyra Therapeutics Inc. | LYRA | NBVM GP LLC DAMORE RICHARD A NORTH BRIDGE VENTURE PARTNERS V A LP NORTH BRIDGE VENTURE PARTNERS V-B LP North Bridge Venture Partners VI L P North Bridge Venture Management V L.P. North Bridge Venture Management VI L.P. 10% Owner | 2,369,667 | $4.22 | $9,999,995 | 1,318,133 (Indirect) | View |
| 2022-04-12 Purchase | 2022-04-14 4:08 pm | Lyra Therapeutics Inc. | LYRA | ANDERSON EDWARD T Director 10% Owner | 2,488,150 | $4.22 | $10,499,993 | 1,436,616 (Indirect Direct) | View |
| 2022-04-12 Purchase | 2022-04-13 7:16 pm | Lyra Therapeutics Inc. | LYRA | Waksal Harlan Chairman | 236,966 | $4.22 | $999,997 | 236,966 (Direct) | View |
| 2021-06-17 Purchase | 2021-06-22 4:28 pm | Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director | 3,500 | $8.9699 | $31,395 | 3,500 (Direct) | View |
| 2020-12-16 Purchase | 2020-12-17 4:05 pm | Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director | 1,025 | $9.72 | $9,963 | 1,025 (Direct) | View |
| 2020-05-05 Purchase | 2020-05-29 5:34 pm | Lyra Therapeutics Inc. | LYRA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive LS (A) LLC EDELMAN JOSEPH Director 10% Owner | 625,000 | $16 | $10,000,000 | 3,222,561 (Indirect) | View |
| 2020-05-05 Purchase | 2020-05-15 6:16 pm | Lyra Therapeutics Inc. | LYRA | Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Soleus Capital Master Fund L.P. Soleus Capital LLC Soleus Capital Group LLC Levy Guy 10% Owner | 155,000 | $16 | $2,480,000 | 155,000 (Indirect) | View |
| 2020-05-05 Sale | 2020-05-15 6:16 pm | Lyra Therapeutics Inc. | LYRA | Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Soleus Capital Master Fund L.P. Soleus Capital LLC Soleus Capital Group LLC Levy Guy 10% Owner | 16,909 | $16 | $270,544 | 155,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-04 Option Award | 2022-03-08 4:26 pm | N/A 2032-03-03 | Lyra Therapeutics Inc. | LYRA | TOBIN JAMES R Director | 14,500 | $0 | 14,500 (Direct) | View |
| 2022-02-16 Option Award | 2022-02-18 5:12 pm | N/A 2032-02-15 | Lyra Therapeutics Inc. | LYRA | Palasis Maria CEO | 175,000 | $0 | 175,000 (Direct) | View |
| 2022-02-16 Option Award | 2022-02-18 5:09 pm | N/A 2032-02-15 | Lyra Therapeutics Inc. | LYRA | Waksal Harlan Chairman | 520,000 | $0 | 520,000 (Direct) | View |
| 2022-02-12 Option Award | 2022-02-15 9:31 pm | N/A 2032-02-11 | Lyra Therapeutics Inc. | LYRA | Noyes Corinne See Remarks | 32,000 | $0 | 32,000 (Direct) | View |
| 2022-02-12 Option Award | 2022-02-15 9:31 pm | N/A 2032-02-11 | Lyra Therapeutics Inc. | LYRA | Palasis Maria CEO | 127,400 | $0 | 127,400 (Direct) | View |
| 2022-02-12 Option Award | 2022-02-15 9:30 pm | N/A 2032-02-11 | Lyra Therapeutics Inc. | LYRA | Nelson Pamela E. VP | 30,000 | $0 | 30,000 (Direct) | View |
| 2022-02-12 Option Award | 2022-02-15 9:30 pm | N/A 2032-02-11 | Lyra Therapeutics Inc. | LYRA | Cavalier Jason CFO | 15,605 | $0 | 15,605 (Direct) | View |
| 2022-02-12 Option Award | 2022-02-15 9:30 pm | N/A 2032-02-11 | Lyra Therapeutics Inc. | LYRA | Richard Robert E. VP | 35,000 | $0 | 35,000 (Direct) | View |
| 2021-09-13 Option Award | 2021-09-15 5:44 pm | N/A 2031-09-12 | Lyra Therapeutics Inc. | LYRA | Cavalier Jason CFO | 104,000 | $0 | 104,000 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 6:28 pm | N/A 2031-05-25 | Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 6:25 pm | N/A 2031-05-25 | Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 6:24 pm | N/A 2031-05-25 | Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 6:24 pm | N/A 2031-05-25 | Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 6:23 pm | N/A 2031-05-25 | Lyra Therapeutics Inc. | LYRA | Smith W Bradford Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2021-05-26 Option Award | 2021-05-28 6:23 pm | N/A 2031-05-25 | Lyra Therapeutics Inc. | LYRA | ANDERSON EDWARD T Director | 7,250 | $0 | 7,250 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:05 pm | N/A 2031-02-07 | Lyra Therapeutics Inc. | LYRA | Elsey R Don CFO | 45,000 | $0 | 45,000 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:05 pm | N/A 2031-02-07 | Lyra Therapeutics Inc. | LYRA | Palasis Maria CEO | 120,000 | $0 | 120,000 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:05 pm | N/A 2031-02-07 | Lyra Therapeutics Inc. | LYRA | Noyes Corinne See Remarks | 30,000 | $0 | 30,000 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:05 pm | N/A 2031-02-07 | Lyra Therapeutics Inc. | LYRA | Nelson Pamela E. VP | 13,000 | $0 | 13,000 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 4:05 pm | N/A 2031-02-07 | Lyra Therapeutics Inc. | LYRA | Richard Robert E. VP | 18,000 | $0 | 18,000 (Direct) | View |
| 2020-10-27 Option Award | 2020-10-29 8:45 pm | N/A 2030-10-26 | Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director | 14,500 | $0 | 14,500 (Direct) | View |
| 2020-08-03 Option Award | 2020-08-05 4:06 pm | N/A 2030-08-03 | Lyra Therapeutics Inc. | LYRA | Nelson Pamela E. VP | 35,000 | $0 | 35,000 (Direct) | View |
| 2020-06-24 Option Award | 2020-06-26 4:18 pm | N/A 2030-06-24 | Lyra Therapeutics Inc. | LYRA | Richard Robert E. VP | 35,000 | $0 | 35,000 (Direct) | View |
| 2020-05-05 Exercise | 2020-05-15 6:16 pm | N/A N/A | Lyra Therapeutics Inc. | LYRA | Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Soleus Capital Master Fund L.P. Soleus Capital LLC Soleus Capital Group LLC Levy Guy 10% Owner | 31,382 | $8.63 | 155,000 (Indirect) | View |
| 2020-05-05 Conversion | 2020-05-15 6:16 pm | N/A N/A | Lyra Therapeutics Inc. | LYRA | Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Soleus Capital Master Fund L.P. Soleus Capital LLC Soleus Capital Group LLC Levy Guy 10% Owner | 15,716,828 | $0 | 155,000 (Indirect) | View |
| 2020-05-05 Exercise | 2020-05-15 6:16 pm | 2020-01-27 2030-01-27 | Lyra Therapeutics Inc. | LYRA | Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Soleus Capital Master Fund L.P. Soleus Capital LLC Soleus Capital Group LLC Levy Guy 10% Owner | 31,382 | $0 | 155,000 (Indirect) | View |
| 2020-04-30 Ownership | 2020-05-15 6:13 pm | 2020-01-27 2030-01-27 | Lyra Therapeutics Inc. | LYRA | Soleus Private Equity GP I LLC Soleus Private Equity Fund I L.P. Soleus PE GP I LLC Levy Guy 10% Owner | 0 | $0 | 31,382 (Indirect) | View |
| 2020-05-05 Exercise | 2020-05-06 9:10 pm | N/A N/A | Lyra Therapeutics Inc. | LYRA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive LS (A) LLC EDELMAN JOSEPH Director 10% Owner | 480,825 | $8.63 | 1,288,446 (Indirect) | View |
| 2020-05-05 Conversion | 2020-05-06 9:10 pm | N/A N/A | Lyra Therapeutics Inc. | LYRA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive LS (A) LLC EDELMAN JOSEPH Director 10% Owner | 84,310,584 | $0 | 1,288,446 (Indirect) | View |
| 2020-05-05 Exercise | 2020-05-06 9:10 pm | 2020-01-17 2030-01-10 | Lyra Therapeutics Inc. | LYRA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive LS (A) LLC EDELMAN JOSEPH Director 10% Owner | 480,825 | $0 | 1,288,446 (Indirect) | View |
| 2020-05-05 Tax Withholding | 2020-05-06 9:10 pm | N/A N/A | Lyra Therapeutics Inc. | LYRA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive LS (A) LLC EDELMAN JOSEPH Director 10% Owner | 259,346 | $16 | 1,288,446 (Indirect) | View |